EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS069-04797 
Organism
Homo sapiens 
Tissue/cell
GM18951 
Coordinate
chr2:85664180-85666220 
TF binding sites/motifs
Number: 5             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF16MA0741.1chr2:85665114-85665125GGGGGCGGGGC-6.02
KLF4MA0039.3chr2:85665576-85665587CCACACCCTCC+6.32
KLF5MA0599.1chr2:85665115-85665125GGGGCGGGGC-6.02
LBX2MA0699.1chr2:85665325-85665335GCCAATTAGC+6.02
NR2C2MA0504.1chr2:85664988-85665003TGCCCTCCGACCCCG-6.33
Number of super-enhancer constituents: 29             
IDCoordinateTissue/cell
SE_00851chr2:85664354-85664594Adipose_Tissue
SE_00851chr2:85665679-85665949Adipose_Tissue
SE_01529chr2:85663480-85666708Adrenal_Gland
SE_03329chr2:85662175-85664878Brain_Angular_Gyrus
SE_03329chr2:85664969-85666959Brain_Angular_Gyrus
SE_04039chr2:85659765-85667780Brain_Anterior_Caudate
SE_05066chr2:85659776-85667840Brain_Cingulate_Gyrus
SE_05969chr2:85659679-85668106Brain_Hippocampus_Middle
SE_06962chr2:85659744-85667954Brain_Hippocampus_Middle_150
SE_08005chr2:85659743-85667963Brain_Inferior_Temporal_Lobe
SE_08853chr2:85663407-85664870Brain_Mid_Frontal_Lobe
SE_08853chr2:85665119-85666269Brain_Mid_Frontal_Lobe
SE_09675chr2:85663395-85667074CD14
SE_12755chr2:85665208-85665438CD34_fetal
SE_31856chr2:85659842-85666966Gastric
SE_33512chr2:85659775-85666880H2171
SE_34480chr2:85662562-85664399HCT-116
SE_34718chr2:85659757-85667655HeLa
SE_37700chr2:85659671-85666984HSMMtube
SE_40483chr2:85663522-85666339K562
SE_42809chr2:85659836-85666478Lung
SE_47420chr2:85659792-85666848Panc1
SE_47644chr2:85664072-85666224Pancreas
SE_49417chr2:85662161-85666850Right_Atrium
SE_50604chr2:85662226-85666450Sigmoid_Colon
SE_52950chr2:85663048-85666692Small_Intestine
SE_56638chr2:85663845-85666147u87
SE_65543chr2:85662091-85667108Pancreatic_islets
SE_69119chr2:85663010-85665329H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr28566454485665596
Enhancer Sequence
TGTCCTGCAC GAGGGAGGCC CCACGGTTCT CAAGTGTCAC AGGGCAGACT AGCCTGCAGT 60
TATGGAGATG CAGGAGCTAG GCCCGGGCAG AAAGGGCCAG CCGTTTCTAC CCCAGATTGG 120
GGCTTTTACT TTTAGATGCT CTGTGCCGAG CGAGGCCAGG CTGAGTGGCT GATTTTTGTT 180
TTGATTTGTG GGAGTTGGAG TGGGGAAGGG AGGGAGGCGC AGTGCTGTCT CTGACACCCT 240
ATTAAATGAG GAGAATGGAG TCCATTACCT ACTCCTCCAA CACCTACTTA CTGTACCTTG 300
CTCCCGGGGG AGTGATGAGC CTGATTTTGG GAGCTTGGTG TTGTCTAGAG GAGGGGAGAC 360
AGTGGGCCCC GGGAAACAAC TAGATCTGAT GCTCCAGTCT AGAGTCAAAG CTAGGGAAAG 420
CTGAACAGTG GCGCTCAGAG AAGACAGGAC AGCGGGCGAG AGCTTGGGGG GCGATGGGAG 480
GTGGAGAGGC ACTCCAGGTC CCCAGGGGGC CAGGCGGAGC TGCGGGACAG GGCGCAGACC 540
CCGAGGCCCA GGGAGCACCG GGTGGCCGGC GGCCTGCAGG CTGGCGAGGG CGTCGGGCGG 600
CGCAGGGCAG GCCAGGGGGC GGGGGCGTCT GGGGCCCTGG CGTGGCGCCC GGAACACCCC 660
GTGCCGGAAG CTCCATGTGA CCGTGACTCC GCAGAAGCCG CGAGCGCAGC GAAACAAAGG 720
GCGGCTCTGC GGCCGCCTCG AGCTCAGGCT GGCACCGAGG GCCCGGACCC CCATCCCACT 780
CCGCACCCCC GGGCCTCCCG GCCCTTCTTG CCCTCCGACC CCGGGCTCTG GCAGGGCCGG 840
GAGGCGCAGG AACCCCGCGG GGGATGGGGC CGGCGGACTG GCACTGAAGA CACTGGGATG 900
CAAGCGGGAG GCTGGGGGCG GGGGGCTGGG GGCGGGGGGC GGGGCTGCAG GGCGTGGACG 960
GTCTCCGTCA GTGCCGGCTC CTGCGGATTA CCGCCTCGGA ACCGTCATTT CTTGCCTGTA 1020
ATAAGGGGAA GATAATCGTC CCTACGTAAT CGTCCTCCGG TTAGGAGGCT TAAGTGAGAC 1080
ATGCCACGTA AAGGGATGCC TGCGTAAAGG GGTGCCTGAT GGGGAGAAGG AAACACCAAA 1140
TTCGGGCCAA TTAGCTGCCA CTGTCAAAAT CGCTGGGAAG ACACAGTTAT CGGCCAGGGC 1200
ACCAGGAAGG GGCACGGGCT GGGGCAGCCG TCATAGGGGT GGGGTGCGGG GGGCGGGTGG 1260
ACACCGGTGT GTGTATGTGA GGAAGGGACC AGCAGCGGAG GCCTCTAGCA GAAACAGGAG 1320
AATAGGAGAC CGGCAAGACA CGCCTTCAGC CCCACTGGCC CAGCCCTGGC TCCCTCCAGA 1380
ACCTGGCCTC CGTCCTCCAC ACCCTCCCCA GCATCATCCC GCAGGCCCGC AGGGGCTGTG 1440
GAGGCTGGGG AGCTTGGCAC CTTGGGCTGG GACTCAGGGT ACAGTCAGCC CCCTAGTATC 1500
CCCACAACAG CTCTACAGGT TCCACTTCCC TAGAGGAGCT CTCCACTCTG TGGCCACAAA 1560
GGCCTCGGGA CTCAGGGGCC TGTTGTTACT GAGCCCCGCA GCCATGAGGC ATTTGGTGGG 1620
GGAGTAGAAG TTACAGCCCA GAGCTCCTGA AGTTAATGGC CCAACAGGGA CTCTGATTTT 1680
TCCCAGCTTA GGGACTAACT TCAAGGAATT AGCCTCCATT CCTCCCCTCC CTGGGGAGAA 1740
AGAGAGGAGG AGCAGCTAGG CAGTGGGACA GTCTGTAACC CGGGCCCTTG AGGGCAAAAA 1800
GGAACCTGTT GCCTGCCCAG TACCTCCTCA GCTTGCAGGC CTGAGCAGAT GGCCCCTTGT 1860
CCAGGGAGCC TTCACCACTC CCCCAGCCTG GGCCCAGGTA CTTAGGCCGT CGTCTCTTCA 1920
CTCCCAGGAC AGACCGGCTA CTACTGCCCA CTATTGGATA TTCTGGGCCT GGAATACAGC 1980
AGGTGGCGTG TATTTATTGA AAGAGTGATC AAATAGGTCA AGTCTATTCT GGATTCCTCT 2040